This information was published on 2025-12-11T05:16:43 for IP Right Filed Published.
| Field | Value |
| (210) | 2611252 (IR 1890417) |
| (220) |
05 Nov 2025
|
| (300) |
US, 05 May 2025, 99170293
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of erythropoietic porphyria (EPP), X-linked protoporphyria (XLPP), genetic diseases and disorders, dermatological diseases and disorders, hematological diseases and disorders, liver diseases and disorders, and photosensitivity. |
| (540) | BIXAMPLY |
| (550) | Word |
| (730) |
Disc Medicine, Inc.
|
Find out more about publications on the About page.